Antony Hou

Statistics

Publications

Citations

895

H-Index

Active since

2009

Affiliations

Altoona Center for Clinical Research(Current)

Antony Hou is an author at Altoona Center for Clinical Research specializing in inflammatory arthritis, rheumatology, and rheumatoid arthritis therapy.

Publications per year

2009–2017

Publications

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

Maxime Dougados, K. Kissel, Tom Sheeran et al. · Annals of the Rheumatic Diseases · 2012 · 287 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study

Philip J. Mease, Nathan Wei, Edward J. Fudman et al. · The Journal of Rheumatology · 2009 · 112 citations · Full text

Medicine, Clinical Sciences, Immunology +17

1–3 of 3